Merck & Co ( NYSE:MRK ) has emerged victorious in its fourth-quarter performance, exceeding market expectations fueled by the remarkable success of its flagship cancer immunotherapy drug, Keytruda. The pharmaceutical giant reported robust financials, driven by a 21% surge in Keytruda sales, catapulting it to the status of the world's best-selling prescription...
SPDR Select Sector Fund – Healthcare Index AMEX:XLV The chart speaks for itself, we have our breakout levels and our break down levels. We enter on a breakout and set a stop 5% under that support and we exit and or short if we fall under the two underside support levels. Below I outline some reasons why the healthcare sector is worth paying attention too....
Navigating the Oncology Frontier with Harpoon Therapeutics Acquisition In a significant strategic move, pharmaceutical giant Merck & Co. ( NYSE:MRK ) has announced its plans to acquire cancer drugmaker Harpoon Therapeutics Inc. ( NASDAQ:HARP ) in a transformative deal valued at $680 million. The move aims to solidify Merck's leadership position in the highly...
Hi, according to my analysis of mrk stock. The stock looks negative. The stock broke the bottom at the 106 level. It also broke the ascending channel to the upside, as shown in the analysis. These are all indications that the stock is still under pressure from sellers. good luck for everbody
Merck and Company (MRK) is trading within a Channel Down since the May 03 High. Even though the price didn't touch the bottom (Lower Lows trend-line) of the Channel Down, having completed 4 straight green 1D candles indicates that most likely we have seen the new low of this sequence. Assuming the current bullish wave will make at least a +7.10% extension like the...
The pool-season is about to start, and Merck has already secured its place on the water slide, which should take it further downwards below the support at $110.66. However, there is still a 35% chance that the share might catch a bubbling fountain which could push it above the resistance at $119.65. In that case, we would expect Merck to develop a new top in the...
This strategy dissects the dual nature of big pharmaceutical firms like Johnson & Johnson, Pfizer, Moderna, and Merck & Co viewed through base Fibonacci Extension Clustering. Despite big pharma's significant contributions to healthcare, these firms have benefited from questionable practices, including price manipulation and exploiting addictions . Price...
- MRK is in a rising trend channel in the medium long term. - The price has risen strongly since the positive signal from the rectangle formation at the break through resistance at 95.58. - The stock has broken up through resistance at 115. - Volume tops and volume bottoms correspond badly with tops and bottoms in the price. - The short term momentum of the stock...
High Quality and Undervalued NYSE:MRK These eight indicators are all Bullish. If you owned NYSE:MRK for the last 5 years, then you have doubled your investment. There is no guarantee of the future but it looks like the near future target price is $121 Earnings Date: 27th April 2023 On-balance volume (OBV): Bullish Accumulation/distribution line:...
Initial Notes - Personally did not trade today, Analysis was on point, rest of week should be exciting SPY - So it looks like scenario 3 that I mentioned on my list last night played out today. We saw both targets to the upside and downside get hit. Premarket we were about 15 cents off of the upside target before opening and pushing higher than yesterdays high....
📈 What’s up investors! 📉 Welcome back to another one of 💡“Mike’s Ideas”.💡 I post as I find signals… these signals are based on the personal rules I have built and follow in order to make up what I call the “SST Strategy”. Follow for more ideas in the future!! I have 4 levels marked and colour coded on the Chart. These levels are: 🔴 Red = Stop Loss 🟢 Green =...
1. cvx 2. mrk 3. amgn 4. trv 5. cat 6. ibm 7. ko 8. wmt 9. hon 10. jnj 11. unh 12. mcd 13. gs 14. v 15. axp 16. dow 17. pg 18. ba 19. jpm 20. aapl 21. wba 22. hd 23. csco 24. vz 25. msft 26. mmm 27. dis 28. nke 29. crm 30. intc
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive...
Divergent on the downside across multiple timeframes. Betting on a triangle B formation, now due for a C Wave to the upside. No confirmation yet. Speculating that this might be a very short term event. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in...
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. The company does business as Merck Sharp & Dohme outside the United States and Canada. Merck was able to break the support lines. For now, it completed its pullback to support...
MRK $MRK Continuation Short. TP and SL on chart. Move SL on TP. After TP2, trail with 0.5ATR step and 1.5ATR offset.
Merck and Company Short Term We look to Sell at 93.34 (stop at 96.33) We look to sell rallies. Price action looks to be forming a top. Although the bulls are in control, the stalling positive momentum indicates a turnaround is possible. There is scope for mild buying at the open but gains should be limited. Our profit targets will be 86.55 and 83.96...
One more huge pharma firm that is biting the dust. A giant flat with a C wave confirmed. No way but down on this one. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted,...